trimethoprim has been researched along with Gastric Diseases in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Alessandro, L | 1 |
| Faenza, L | 1 |
| Di Palma, D | 1 |
| Russo, P | 1 |
1 trial available for trimethoprim and Gastric Diseases
| Article | Year |
|---|---|
[Trimethoprim-sulfamethoxazole (TM-SMZ) combination in the treatment of brucellosis].
Topics: Adolescent; Adult; Aged; Brucellosis; Clinical Trials as Topic; Drug Combinations; Drug Eruptions; D | 1974 |